eli lily glp-1 Lilly's Obesity Pill Appears to Work as Well as Injected GLP-1s Novo Nordisk Sues Eli Lilly

It is worth being clear about what this does and does not show

2013;36(Suppl 2):S12738

Potential benefits need to be weighed against the risk of hypoglycemia and lack of long-term data

Consequently, businesses should rethink their operations and revenue streams to offer value that aligns with this new consumer ethos. Market research thus far has indicated that GLP-1 drugs may impact consumer spending on food and beverages namely, on candy and sugary snacks and drinks in shopping regularity, basket size and product choices as these medications affect eating habits in areas such as frequency, portion size and taste preferences

Ahmad E, Lim S, Lamptey R, et al